Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2516.91 (Glytoucan)

Id:3359ca7c-959c-5c2b-8cd6-6b5ec4ecfa93

Glytoucan:G57601KU

Results found

Linked to

	Label	Description
	2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G62968IF-GLYCOSEQ00184268 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G78370NE-GLYCOSEQ00148867 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 has canonical residue n-glycan b-d-galp 8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G92241FG-GLYCOSEQ00084230 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G39809FW-GLYCOSEQ00161639 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G92241FG-GLYCOSEQ00084233 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 has canonical residue n-glycan b-d-glcpnac 36 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G30827KR-GLYCOSEQ00046435 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2516.91 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000006 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G62968IF-GLYCOSEQ00184268 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G78370NE-GLYCOSEQ00148867 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has canonical residue n-glycan b-d-galp 8

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G92241FG-GLYCOSEQ00084230 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G39809FW-GLYCOSEQ00161639 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G92241FG-GLYCOSEQ00084233 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has canonical residue n-glycan b-d-glcpnac 36

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 has glycosequence GLYGEN.GLYCOSEQUENCE:G30827KR-GLYCOSEQ00046435 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2516.91 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000006 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.